New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2013
12:07 EDTZMHZimmer unlikely to be strongly impacted by AAOS guidance, says Wells Fargo
Wells Fargo reports that the American Academy of Orthopedic Surgeons, or AAOS, will recommend against the use of hyaluronic acid, or HA, for osteoarthritis of the knee, while Zimmer is in the process of launching its single injection HA, Gel-one in the U.S. The firm thinks the guidance could have a temporary negative impact on HA, but it doesn't expect the impact on Zimmer to be dramatic. The firm doesn't expect doctors who have already had success with HA to stop using it, and it maintains an Outperform rating on Zimmer.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
07:12 EDTZMHAmerican Academy of Orthopedic Surgeons to hold annual meeting
Subscribe for More Information
07:02 EDTZMHZimmer announces clearance by Japan FTC of pending Biomet merger
Subscribe for More Information
March 18, 2015
12:06 EDTZMHEU set to conditionally approve Zimmer, Biomet deal, Reuters reports
The European Union is set to give conditional approval to Zimmer's proposed acquisition of Biomet, Reuters reports, citing two people with knowledge of the matter. Reference Link
10:52 EDTZMHZimmer deal for Biomet unlikely delayed by DPA, says Piper Jaffray
Subscribe for More Information
10:46 EDTZMHZimmer says DOJ extended Biomet DPA for another year
Subscribe for More Information
March 16, 2015
08:05 EDTZMHZimmer announces first clinical use of Vivacit-E liner
Zimmer announced its first reverse shoulder replacement in the United States using Vivacit-E Liner for the Trabecular Metal Reverse Shoulder System.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use